BLTE
BLTE
US07782B1044
Belite Bio, Inc
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
6.22B EUR
6.2B EUR
6.39B EUR
6.29B EUR
Enterprise Value
--
6.2B EUR
6.39B EUR
5.94B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
68.36x
--
--
--
Price to Sales
--
--
--
--
Price to Book
8.01x
7.98x
8.03x
8.17x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
--
-0.17%
-0.17%
-0.17%
ende